Nephrocare Health Services (NEPHROPLUS)
FAST GROWERFairStock Score: 25/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹539.4 |
| Market Cap | ₹5,958.23 Cr |
| P/E Ratio | 75.76 |
| ROCE | 14.11% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 60.32% |
| Debt/Equity | 0.36 |
| Sales Growth | 31.67% |
| Promoter Holding | 63.85% |
| 52-Week Range | ₹446 — ₹767.95 |
| Sector | Healthcare Services |
| Book Value | ₹391.25 |
Nephrocare Health Services trades with a P/E ratio of 75.76, ROCE of 14.11%, profit growth of 60.32%, debt-to-equity of 0.36. The FairStock Score of 25/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer